The ExaShape line is not seven versions of the same idea. It is seven answers to seven different clinical questions.
A product line can be a convenience or a strategy. When it is a strategy, each configuration exists because a specific clinical scenario asked for it. The ExaShape line is built that way. All seven configurations share the same foundation, bilayer bovine pericardium processed to preserve its collagen architecture, but each is shaped for a different reconstructive decision. Here is how they map.
Prepectoral, direct-to-implant
BioShield Pocket. A meshed bovine pericardium membrane with a patented pocket design for prepectoral reconstruction. It covers the anterior part of implants up to 560 cc in a quick and reproducible way, without the need to suture into the muscle. This is the workhorse for standardised prepectoral DTI.
BioShield Pocket 3D. A pre-shaped, three-dimensional pocket for prepectoral reconstruction, covering the anterior part of implants up to 650 cc in a full non-touch technique. When the priority is a hands-off workflow and a larger implant volume, this is the configuration built for it.
Complex prepectoral
BioShield Pocket PRo. An enhanced bilayer pericardial pocket for complex reconstruction procedures that call for greater mechanical performance. When the case is demanding, this is the reinforced member of the pocket family.
Tailored coverage
PREPEC. A perforated bovine pericardium membrane designed to cover different parts of the implant according to the surgeon’s needs. When a case calls for judgement rather than a fixed pocket, PREPEC provides the flexibility to cover exactly what the anatomy requires.
Subpectoral
Grid. A perforated membrane in a half-moon shape designed for subpectoral reconstruction, covering the lower part of the implant. For dual-plane and subpectoral approaches, Grid supports the lower pole where support is needed most.
Two-stage
Expander. A rectangular perforated membrane designed for tissue expander use, supporting the expansion phase in two-stage reconstruction. When the pathway is staged, Expander is built for the first act.
Nipple-areola reconstruction
NAC. A perforated membrane designed to support nipple-areola complex reconstruction. For the finishing stage of the reconstructive journey, NAC provides biological support where detail matters.
Choosing across the line
The value of a full line is that the decision moves from “will this device fit my case” to “which configuration was designed for it.” Prepectoral or subpectoral. Direct-to-implant or two-stage. Standardised pocket or tailored coverage. Whole reconstruction or nipple-areola detail. In each case, the underlying material behaves the same predictable way, moving through early inflammation, neoangiogenesis, collagen formation, and remodelling, so the surgeon’s choice is about fit and technique, not about relearning the biology each time.
One material philosophy. Seven configurations. A single line that follows the patient from the first operation to the last.
Seven decisions. One line engineered to answer each of them.
Match a configuration to your case mix with the Decision Simulator, estimate the economics with the Cost-Per-Case Calculator, or request a demo.
For Healthcare Professionals Only. The full ExaShape line is CE marked per EU MDR 2017/745. Images for illustrative purposes only.
Important information This article is general education, not medical advice. Tap to read the full medical, regulatory & legal notice.
This article is provided by Advanced Biomedical Concept for general informational and educational purposes only. It does not constitute medical, surgical, diagnostic, or other professional healthcare advice, and it is not a substitute for consultation with a suitably qualified healthcare professional. Reading it creates no doctor–patient or other professional relationship. Nothing here should be used to diagnose, treat, cure, or prevent any disease or condition, or to make decisions about medical care. Always seek the advice of a physician or other qualified provider with any questions about a medical condition or treatment, and never disregard or delay professional advice because of something you have read here.
Any reference to Advanced Biomedical Concept products (including ExaShape and ExaFat) is provided for general information only. These are medical devices intended to be used by appropriately trained healthcare professionals strictly in accordance with their applicable, current Instructions for Use (IFU). Regulatory status (including CE marking and classification under the EU Medical Device Regulation), market availability, and approved indications differ between countries and may change over time; a device referred to here may not be available or approved in your country. This content is not intended as, and must not be relied upon as, a statement or claim of safety, clinical performance, or efficacy beyond what is set out in the applicable IFU and current regulatory approvals. Product-specific information is directed at healthcare professionals and is not intended to promote, advertise, or offer any medical device to the general public where such promotion is restricted or prohibited by law.
Statements reflect information believed to be accurate at the date of publication and may be updated or corrected without notice. Any statements regarding the future are expectations or general views, not guarantees. Clinical outcomes depend on many individual factors, results vary from person to person, and no particular result is promised or implied. Where third-party studies, sources, or external links are referenced, they are provided for convenience and information only and do not imply endorsement, and Advanced Biomedical Concept is not responsible for their content.
To the fullest extent permitted by applicable law, Advanced Biomedical Concept and its officers, employees, contributors, and representatives (each acting in that capacity and on behalf of Advanced Biomedical Concept) accept no liability for any loss, injury, or damage of any kind arising directly or indirectly from use of, or reliance on, this content. Nothing in this notice excludes or limits any liability that cannot lawfully be excluded or limited.
Questions about this material can be directed to us via our contact page.
Last reviewed: July 2, 2026.